Skip to main content
SpringerLink
Log in

Is IDH mutation status associated with 18F-FDopa PET uptake?

  • Letter to the Editor
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 04 February 2020

The Original Article was published on 03 January 2019

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cicone F, Carideo L, Scaringi C, Arcella A, Giangaspero F, Scopinaro F, et al. 18F-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma. Ann Nucl Med. 2019;33(4):295–302. https://doi.org/10.1007/s12149-018-01328-33.

    Article  CAS  PubMed  Google Scholar 

  2. Verger A, Metellus Ph, Sala Q, Colin C, Bialecki E, Taieb D, et al. IDH mutation is paradoxically associated with higher 18F-FDOPA PET uptake in diffuse grade II and grade III gliomas. Eur J Nucl Med Mol Imaging. 2017;44:1306–11.

    Article  CAS  Google Scholar 

  3. Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, et al. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0. Eur J Nucl Med Mol Imaging. 2019;46:540–57.

    Article  CAS  Google Scholar 

  4. Ginet M, Zaragori T, Marie P-Y, Roch V, Gauchotte G, Rech F, et al. Integration of dynamic parameters in the analysis of 18F-FDopa PET imaging improves the prediction of molecular features of gliomas. Eur J Nucl Med Mol Imaging. 2019. https://doi.org/10.1007/s00259-019-04509-y.

    Article  PubMed  Google Scholar 

  5. Cicone F, Carideo L, Minniti G, Scopinaro F. The mean striatal 18F-DOPA uptake is not a reliable cut-off threshold for biological tumour volume definition of glioma. Eur J Nucl Med Mol Imaging. 2019;46:1051–3.

    Article  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU-Nancy, Université de Lorraine, 54000, Nancy, France

    Timothée Zaragori & Antoine Verger

  2. IADI, INSERM, UMR 1254, Université de Lorraine, 54000, Nancy, France

    Timothée Zaragori & Antoine Verger

  3. Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, Aix-Marseille Université, Timone University Hospital, 13000, Marseille, France

    Eric Guedj

  4. CERIMED, Aix-Marseille Université, 13000, Marseille, France

    Eric Guedj

  5. Aix-Marseille Université, CNRS, Ecole Centrale de Marseille, UMR 7249, Institut Fresnel, 13000, Marseille, France

    Eric Guedj

Authors
  1. Timothée Zaragori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric Guedj
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antoine Verger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Timothée Zaragori.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zaragori, T., Guedj, E. & Verger, A. Is IDH mutation status associated with 18F-FDopa PET uptake?. Ann Nucl Med 34, 228–229 (2020). https://doi.org/10.1007/s12149-020-01442-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-020-01442-1

Search

Navigation